Abstract:Objective To investigate the current status on the off-label prescribing of psychoactive drugs of inpatients with schizophrenia,depression,bipolar disorder in Jining Psychiatric Hospital,and provide basic data in order to make "expert consensus on off-label prescribing of psychoactive drugs in psychiatry".Methods 834 inpatients with schizophrenia,depression or bipolar disorder were enrolled in this study by stratified cluster sampling.These patients were discharged from Jining Psychiatric Hospital from January 1st 2017 to December 31th 2017.The self-edited survey on the off-label prescribing of psychoactive drugs was used to investigate these patients' using psychoactive drugs information as inpatients during 2017.To analyze the off-label prescribing situation and rationality according to the specification of psychoactive drugs and guidelines for the prevention and treatment of mental disorders respectively.Results There were 834 inpatients (schizophrenia,n=334,40.0％;depression,n=275,33.0％;bipolar disorder,n=225,27％) in this study.The total rate of off-label prescribing was 85.9％ (716/834).The rate of off-label indication was 85.1％ (710/834).The rate of overdosing was 9.4％(78/834).The rate of off-label in children and adolescents patients was 18.2％(8/44),and in geriatric patients was 18.4％(23/125).The rates of off-label indication were 71.6％(239/334),96.4％(265/275),91.6％(206/225) in schizophrenia,depression and bipolar disorder respectively.The off-label prescribing of anti-anxiety drugs and sedative hypnotics belonged to no grade recommendation.The off-label prescribing of patients with schizophrenia belonged to no grade recommendation.Other off-label prescribing of psychoactive drugs mostly belonged to A-level recommendation and B-level recommendation.Only 2 cases were D-level recommendation.The rate of the off-label indication of mood stabilizers in patients with bipolar disorder was 78.6％(162/206),because sodium valproate in China has no indication to treat bipolar disorder.Conclusions It is very common psychoactive drugs are used with off-label prescribing in the investigated hospital.They are mostly in accord with the guideline of prevention and treatment of mental disorders.It is suggested that the off-label prescribing in the clinical work of psychiatry in China has considerable clinical demand,so it is urgent to strengthen the off-label prescribing and make the proper policy.

A present survey on clinical medication of bipolar disorder among provincial,municipal, and county three-class hospitals in Hebei Province

Prescribing Patterns Of Antidepressants, Antipsychotics And Mood Stabilizers In Bipolar Patients Misdiagnosed With Major Depressive Disorder In China

Survey on Medication Treatment Patterns in 125 Patients with Bipolar Disorder

Screening for Bipolar Disorder with the Mood Disorders Questionnaire in Patients Diagnosed As Major Depressive Disorder — the Experience in China

Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: a Multicenter Trial Across China.

Hypomanic Symptoms Assessed by the HCL-32 in Patients with Major Depressive Disorder: a Multicenter Trial Across China.

Gender Differences in Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with Major Depressive Disorder in China

A Cross-Sectional Study on Medication Treatment Patterns of Bipolar Disorder in China

A cross-sectional study on treatment patterns of bipolar disorders in China in 2006

Present Survey on Antipsychotic Medications to the Patients with Schizophrenia in Hebei Province

Survey on Psychotropic Drug Used in Depression in HeBei Province

Investigation and analysis on the frequency of anti -psychotropic drugs of all grades of mental health institutions in Hebei

The status of off-label prescribing drugs in inpatients with schizophrenia, depression, bipolar disorder in Jining Psychiatric Hospital

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom

A survey of antipsychotics combination therapy and its related factors in China 2006

Adjunctive Antidepressant Use In Schizophrenia In China: A National Survey (2002-2012)

Trends of Antipsychotic Drugs Use in Schizophrenia Patients from Hebei Province

Epidemiological survey of mental disorders in the people aged 18 and older in Hebei Province

Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study

Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study